The Cosmetic Products (Safety) Regulations 1996
| (1) | (2) | (3) | (4) |
|---|---|---|---|
| Number in this Schedule | Name of substance | Cross-reference to this Schedule | Cross-reference to Annex II of the Directive |
| 1 | Acenocoumarol (INN) | 396 | 254 |
| 2 | Acetonitrile | — | 393 |
| 3 | 3-(α-Acetonylbenzyl)-4-hydroxycoumarin and its salts | 398, 760 | 203 |
| 4 | 2-Acetoxyethyltrimethylammonium hydroxide and its salts | 6 | 2 |
| 5 | 2-Acetylamino-5-chlorobenzoxazole | 164 | 1 |
| 6 | Acetylcholine and its salts | 4 | 2 |
| 7 | Acetylene chlorides | 249, 757 | 126 |
| 8 | Acetylenic alcohols, their esters, ethers and salts | 17 | 16 |
| 9 | Acetylethyltetramethyltetralin (AETT) | 341 | 362 |
| 10 | 7α-Acetylthio-3-oxopregn-4-ene-17α,17β-propionolactone | 649 | 4 |
| 11 | Aconitine and its salts | — | 12 |
| 12 | Aconitum napellus L. (leaves, roots and galenical preparations) | — | 11 |
| 13 | Adonis vernalis L. and its preparations | — | 13 |
| 14 | Adrenaline | 269, 314 | 14 |
| 15 | Alkali pentacyanonitrosylferrate(2-) | 602–3, 644–5 | 255 |
| 16 | O-Alkyldithiocarbonic acids, salts of | 761 | 336 |
| 17 | Alkyne alcohols, their esters, ethers and salts | 8 | 16 |
| 18 | Alloclamide (INN) and its salts | 22 | 19 |
| 19 | Allyl isothiocyanate | — | 18 |
| 20 | 2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts | — | 224 |
| 21 | N-Allylnormorphine, its salts and ethers | 492 | 20 |
| 22 | 2-Allyloxy-4-chloro-N-[2-(diethylamino)-ethyl]benzamide and its salts | 18 | 19 |
| 23 | Alypine and its salts | 45, 109 | 143 |
| 24 | Ambenonium chloride (INN) | (527) | 132 |
| 25 | 4-(or p-)Aminobenzoic acid esters | — | 167 |
| 26 | 2-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts | — | 29 |
| 27 | Aminocaproic acid (INN) and its salts | 31 | 7 |
| 28 | 2-Amino-5-chlorobenzoxazole | 768 | 24 |
| 29 | 4-Amino-N-(2-diethylaminoethyl)benzamide, its salts and derivatives | 607 | 25 |
| 30 | Aminoheptane, its isomers and salts | 748 | 25 |
| 31 | 6-Aminohexanoic acid and its salts | 27 | 7 |
| 32 | α-(Aminomethyl)-3,4-dihydroxybenzyl alcohol and its salts | 517–8 | 257 |
| 33 | 4-Amino-N¹⁰-methylfolic acid | 452 | 6 |
| 34 | 2-Amino-6-methylheptane and its salts | 287, 523 | 28 |
| 35 | 2-Amino-4-methylhexane and its salts | 288, 471 | 30 |
| 36 | 2-Amino-4-nitrophenol | — | 383 |
| 37 | 2-Amino-5-nitrophenol | — | 384 |
| 38 | 4-Amino-2-nitrophenol | — | 412 |
| 39 | 4-(or p-)Aminosalicylic acid and its salts | — | 31 |
| 40 | Aminotoluenes, their isomers, salts and halogenated and sulphonated derivatives | 716 | 32 |
| 41 | Aminoxylenes, their isomers, salts and halogenated and sulphonated derivatives | 763 | 33 |
| 42 | Amitriptyline (INN) and its salts | 283 | 146 |
| 43 | Ammi majus and its galencial preparations | — | 35 |
| 44 | Amphetamine (INN), its salts and derivatives and salts of those derivatives | (678) | 21 |
| 45 | Amydricaine and its salts | 23, 109 | 143 |
| 46 | Amylene chloride | 250 | 36 |
| 47 | Amyl 4-dimethylaminobenzoate, mixed isomers | 532 | 381 |
| 48 | Amyl nitrites | — | 247 |
| 49 | Amylobarbitone and its salts | (69) | 220 |
| 50 | Amylocaine and its salts | 281 | 50 |
| 51 | Anamirta cocculus L. (fruit) | — | 106 |
| 52 | Substances with androgenic effect | — | 37 |
| 53 | Aniline, its salts and halogenated and sulphonated derivatives | — | 22 |
| 54 | Anthracene oil | — | 38 |
| 55 | Anti-androgens with steroid structure | — | 390 |
| 56 | Antibiotics | — | 39 |
| 57 | Antimony and its compounds | — | 40 |
| 58 | Apocynum cannabinum L. and its preparations | — | 41 |
| 59 | Apomorphine and its salts | 694 | 42 |
| 60 | Apronalide | 419 | 216 |
| 61 | Arecoline | 482 | 238 |
| 62 | Aristolochic acid and its salts | — | 365 |
| 63 | Arsenic and its preparations | — | 43 |
| 64 | Atropa belladonna L. and its preparations | — | 44 |
| 65 | Atropine, its salts and derivatives | — | 45 |
| 66 | Azacyclonol (INN) and its salts | 304 | 286 |
| 67 | Azamethonium bromide (INN) | (473) | 121 |
| 68 | Barbitone and its salts | (69) | 220 |
| 69 | Barbiturates | various | 220 |
| 70 | Barium salts (except barium sulphate, barium sulphide under the condition laid down in Part I of Schedule 2 for alkaline earth sulphides, and lakes, salts and pigments prepared from those colouring agents identified in column 1 of Schedule 3 by “*” immediately after the name or colour index number) | — | 46 |
| 71 | Bemegride (INN) and its salts | 336, 337 | 183 |
| 72 | Benactyzine (INN) | 257 | 157 |
| 73 | Bendrofluazide and its derivatives | 74, 90 | 53 |
| 74 | Bendroflumethiazide (INN) and its derivatives | 73, 90 | 53 |
| 75 | Benzamine and its salts | 741 | 51 |
| 76 | Benzatropine (INN) and its salts | 300 | 158 |
| 77 | Benzazepines, their salts and derivatives | 89 | 49 |
| 78 | Benzene | — | 47 |
| 79 | Benzene-1,2-diol | 153, 627 | 408 |
| 80 | Benzene-1,2,3-triol | 628 | 409 |
| 81 | Benzethonium chloride (INN) | 92 | 415 |
| 82 | 2-Benzhydryloxyethyldimethylamine and its salts | 295 | 339 |
| 83 | Benzidine | 242 | 26 |
| 84 | Benzilonium bromide (INN) | 95 | 60 |
| 85 | 2-Benziloyloxymethyl-1,1-dimethylpyrrolidinium methyl sulphate | 599 | 239 |
| 86 | Benzimidazolone | 87, 266 | 48 |
| 87 | Benzimidazol-2(3H)-one | 86, 266 | 48 |
| 88 | Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol (except natural content of essences) | 211 | 357 |
| 89 | Benzodiazepines, their salts and derivatives | 77 | 49 |
| 90 | Benzothiadiazine and its derivatives | 73, 74 | 53 |
| 91 | Benzoyl peroxide | — | 382 |
| 92 | Benzyl(dimethyl)(2-{2-[4-(1,1,3,3-tetramethybutyl)phenoxy]ethoxy}-ethyl)ammonium chloride | 81 | 415 |
| 93 | 3-(N-Benzylhydrazinocarbonyl)-5-methylisoxazole | 414 | 52 |
| 94 | Benzylideneacetone | 564 | 356 |
| 95 | 3-Benzyloxy-1,1-diethylpyrrolidine hydrobromide | 84 | 60 |
| 96 | 4-Benzyloxyphenol | (390), 487 | 178 |
| 97 | 2-[Benzyl-N-(2-pyridyl)amino]-ethyldimethylamine | 623, 745 | 347 |
| 98 | Bergapten(e) (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (356) | 358 |
| 99 | Beryllium and its compounds | — | 54 |
| 100 | Betamethasone (INN) | (360) | 300 |
| 101 | Betoxycaine (INN) and its salts | 256 | 23 |
| 102 | BHC (ISO) (gamma-BHC) | 369, 371, 428 | 195 |
| 103 | Bietamiverine (INN) | 260 | 287 |
| 104 | 1,6-Bis(2-chloroethylamino)-1,6-dideoxymannitol and its salts | 436 | 89 |
| 105 | 2-[Bis(2-chloroethyl)amino]-1-oxa-3-aza-2-phosphacyclohexane 2-oxide and its salts | 108, 230 | 88 |
| 106 | N,N-Bis(2-chloroethyl)methylamine and its salts | 160, 490 | 87 |
| 107 | N,N-Bis(2-chloroethyl)methylamine N-oxide and its salts | 491 | 86 |
| 108 | N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-ylamine p-oxide and its salts | 105, 230 | 88 |
| 109 | 1,1-Bis(dimethylaminomethyl)propyl benzoate and its salts | 23, 45 | 143 |
| 110 | Bis(hydroxyalkyl)amines, not further N-substituted | 254, 273, 640 | 411 |
| 111 | 2,2-Bis(hydroxymethyl)butan-1-ol trinitrate | 613 | 206 |
| 112 | 2,6-Bis(β-hydroxyphenethyl)-1-methylpiperidine and its salts | 430 | 219 |
| 113 | 3,3-Bis(4-hydroxyphenyl)phthalide | 557 | 417 |
| 114 | Bis(8-hydroxyquinolinium) sulphate, except for the uses provided for in entry number 51 in Part 1 of Schedule 2 | (400, 531) | 395 |
| 115 | Bithionol (INN) | 705 | 352 |
| 116 | Bretylium tosilate (INN) (Bretylium tosylate) | 119 | 56 |
| 117 | Bromine, elemental | — | 55 |
| 118 | Bromisoval (INN) | 121 | 58 |
| 119 | p-Bromobenzylethyldimethylammonium p-toluenesulphonate | 116 | 56 |
| 120 | 2-Bromo-2-ethylbutyrylurea | 149 | 57 |
| 121 | 2-Bromo-3-methylbutylrylurea | 118 | 58 |
| 122 | 1-p-Bromophenyl-1-(2-pyridyl)-3-dimethylaminopropane and its salts | 123 | 59 |
| 123 | Brompheniramine (INN) and its salts | 122 | 59 |
| 124 | Brucine | — | 62 |
| 125 | Butanilicaine (INN) and its salts | 466 | 90 |
| 126 | Butobarbitone and its salts | (69) | 220 |
| 127 | Butopiprine (INN) and its salts | 129 | 288 |
| 128 | 2-Butoxy-N-(2-diethylaminoethyl)-cinchoninamide and its salts | 191 | 129 |
| 129 | 2-Butoxyethyl phenyl(piperidino)acetate and its salts | 127 | 288 |
| 130 | 1-Butyl-3-(N-crotonoylsulphanilyl)urea | — | 108 |
| 131 | 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione | 563 | 67 |
| 132 | 4-tert-Butyl-3-methoxy-2,6-dinitrotoluene | 489 | 414 |
| 133 | 4-Butyl-1-phenylpyrazolidine-3,5-dione | 486 | 64 |
| 134 | 1-Butyl-3-(p-methylbenzenesulphonyl)urea | 715 | 65 |
| 135 | 1-Butyl-3-sulphanilylurea | 150 | 66 |
| 136 | 4-Butylthiobenzhydryl 2-(dimethylamino)ethyl sulphide | 143 | 140 |
| 137 | Cadmium and its compounds | — | 68 |
| 138 | Calabar bean | 585 | 281 |
| 139 | Calciferol | 316, (759) | 335 |
| 140 | Cantharides, Cantharis vesicatoria | 647 | 69 |
| 141 | Cantharidin | 378 | 70 |
| 142 | Captan (ISO) | 734 | 370 |
| 143 | Captodiame (INN) | 136 | 140 |
| 144 | Caramiphen (INN) and its salts | 567 | 169 |
| 145 | N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethylammonium salts | 418 | 156 |
| 146 | Carbazole, nitroderivatives of | 508 | 72 |
| 147 | Carbon disulphide | — | 73 |
| 148 | Carbon tetrachloride | 690 | 315 |
| 149 | Carbromal (INN) | 120 | 57 |
| 150 | Carbutamide (INN) | 135 | 66 |
| 151 | Carisoprodol (INN) | 480 | 235 |
| 152 | Catalase | — | 74 |
| 153 | Catechol | 79, 627 | 408 |
| 154 | Cells, tissues or products of human origin | — | 416 |
| 155 | Cephaeline and its salts | — | 75 |
| 156 | Chenopodium ambrosioides (essential oil) | — | 76 |
| 157 | Cherry laurel water | 618 | 291 |
| 158 | Chloral hydrate | 732 | 77 |
| 159 | Chlorine | — | 78 |
| 160 | Chlormethine (INN) and its salts | 106, 490 | 87 |
| 161 | Chlormezanone (INN) | 175 | 91 |
| 162 | 4-Chlorobenzene-1,3-disulfonamide | 194 | 85 |
| 163 | 5-Chloro-1,3-benzoxazol-2(3H)-one | 186 | 82 |
| 164 | N-5-Chlorobenzoxazol-2-ylacetamide | 5 | 1 |
| 165 | 2-Chloro-4-dimethylamino-6-methylpyrimidine | 169, 216 | 83 |
| 166 | 2-Chloro-9-[3-(dimethylamino)-propylidene]thioxanthene (cis-form) and its salts | 183 | 84 |
| 167 | Chloroethane | 327 | 96 |
| 168 | Chloroform | 733 | 366 |
| 169 | 2-Chloro-6-methylpyrimidin-4-yldimethylamine | 165, 216 | 83 |
| 170 | Chlorophacinone (ISO) | 176 | 93 |
| 171 | 1-(p-Chloro-α-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine | 401 | 240 |
| 172 | 2-(4-Chlorophenyl)-1-[4-(2-diethylaminoethoxyl)phenyl]-1-p-tolylethanol | 744 | 92 |
| 173 | 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one | 368 | 185 |
| 174 | 2-(4-Chlorophenyl)-3-methylbutane-2,3-diol | 551 | 95 |
| 175 | 2-(4-Chlorophenyl-3-methyl-1,3-thiazinan-4-one 1,1-dioxide | 161 | 91 |
| 176 | 2-[2-(4-Chlorophenyl)-2-phenylacetyl]indane-1,3-dione | 170 | 93 |
| 177 | 2-[1-(4-Chlorophenyl)-1-phenylethoxy]ethyl-(dimethyl)amine | 180 | 94 |
| 178 | Chloropicrin | 735 | 325 |
| 179 | 3-(4-Chloro-3-sulphamoylphenyl)-3-hydroxyisoindolin-1-one | 184, 185 | 262 |
| 180 | Chlorphenoxamine (INN) | 177 | 94 |
| 181 | Chlorpromazine (INN) | (558) | 320 |
| 182 | Chlorpropamide (INN) | 614 | 79 |
| 183 | Chlorprothixene (INN) and its salts | 166 | 84 |
| 184 | Chlortalidone (INN) | 179, 185 | 262 |
| 185 | Chlorthalidone | 179, 184 | 262 |
| 186 | Chlorzoxazone (INN) | 163 | 82 |
| 187 | Cholecalciferol | (759) | 335 |
| 188 | Choline salts and their esters | — | 168 |
| 189 | Chromium, chromic acid and salts of the acid | — | 97 |
| 190 | Chrysoidine citrate hydrochloride | 562 | 81 |
| 191 | Cinchocaine (INN) and its salts | 128 | 129 |
| 192 | Cincophen (INN), its salts and derivatives and salts of those derivatives | 577 | 8 |
| 193 | Claviceps purpurea Tul., its alkaloids and galenical preparations | 317 | 98 |
| 194 | Clofenamide (INN) | 162 | 85 |
| 195 | Clofenotane (INN) | 232, 731 | 123 |
| 196 | Cobalt benzenesulphonate | — | 101 |
| 197 | Cocculin | 589 | 282 |
| 198 | Colchicine, its salts and derivatives | — | 102 |
| 199 | Colchicoside and its derivatives | — | 103 |
| 200 | Colchicum autumnale L. and its galenical preparations | — | 104 |
| 201 | Colouring agent CI 12075 and its lakes, pigments and salts | — | 397 |
| 202 | Colouring agent CI 12140 | — | 378 |
| 203 | Colouring agent CI 13065 | — | 387 |
| 204 | Colouring agent CI 15585 | — | 401 |
| 205 | Colouring agent CI 26105 | — | 379 |
| 206 | Colouring agent CI 42535 | — | 388 |
| 207 | Colouring agents CI 42555, 42555:1 and 42555:2 | — | 380 |
| 208 | Colouring agent CI 42640 | — | 386 |
| 209 | Colouring agent CI 61554 | — | 389 |
| 210 | Colouring agent CI 45170 and CI 45170:1 | — | 398 |
| 211 | Coniferyl benzoate (except natural content of essences) | 88 | 357 |
| 212 | Coniine | 615 | 290 |
| 213 | Conium maculatum L. (fruit, powder, galenical preparations) | — | 99 |
| 214 | Convallatoxin | — | 105 |
| 215 | Coumetarol (INN) | 454 | 225 |
| 216 | Crimidine (ISO) | 165, 169 | 83 |
| 217 | Croton tiglium (oil) | — | 107 |
| 218 | Curare and curarine | — | 109 |
| 219 | Curarizants, synthetic | — | 110 |
| 220 | 1-(3-Cyano-3,3-diphenylpropyl)-4-ethoxycarbonyl-4-phenylpiperidinium chloride | 296 | 80 |
| 221 | Cyclarbamate (INN) | 229 | 122 |
| 222 | Cyclizine (INN) and its salts | 301 | 159 |
| 223 | Cyclobarbitone and its salts | (69) | 220 |
| 224 | Cyclocoumarol | 267 | 234 |
| 225 | 2-α-Cyclohexylbenzyl(N,N',N'-tetraethyl)trimethylenediamine | 552 | 112 |
| 226 | 2-Cyclohexyl-3,5-dimethylphenol and its salts | 228 | 113 |
| 227 | 1-Cyclohexyl-3-(p-methylbenzenesulphonyl)urea | 363 | 100 |
| 228 | Cyclomenol (INN) and its salts | 226 | 113 |
| 229 | Cyclopentane-1,1-dimethanol dicarbanilate | 221 | 122 |
| 230 | Cyclophosphamide (INN) and its salts | 105, 108 | 88 |
| 231 | Datura stramonium L. and its galenical preparations | 651 | 301 |
| 232 | DDT (ISO) (pp'-DDT) | 195, 731 | 123 |
| 233 | Deanol aceglumate (INN) | 278 | 3 |
| 234 | Decamethonium bromide (INN) | (235) | 214 |
| 235 | Decamethylenebis(trimethylammonium) salts | 234 | 214 |
| 236 | Dextromethorphan (INN) and its salts | 457 | 226 |
| 237 | Dextropropoxyphene (INN) | 280 | 116 |
| 238 | O,O'-Diacetyl-N-allyl-N-normorphine | — | 117 |
| 239 | 2,4-Diaminoanisole and its salts | 455, 461 | 376 |
| 240 | 2,5-Diaminoanisole and its salts | 456, 460 | 377 |
| 241 | 1,2-Diaminobenzene and its salts | 570 | 363 |
| 242 | p,p'-Diaminodiphenyl | 82 | 26 |
| 243 | 2-(2,4-Diaminophenyl)ethanol and its salts | — | 407 |
| 244 | 1,4:3,6-Dianhydrosorbitol 2,5-dinitrate | 421 | 148 |
| 245 | 5-(α,β-Dibromophenethyl)-5-methylhydantoin | — | 119 |
| 246 | Dibromosalicylanilides | 247, 443 | 351 |
| 247 | Dibromsalan (INN) | (246) | 351 |
| 248 | Dichloroethanes | 329, 334 | 125 |
| 249 | Dichloroethylenes | 7, 757 | 126 |
| 250 | 2,3-Dichloro-2-methylbutane | 46 | 36 |
| 251 | Dichlorosalicylanilides | — | 349 |
| 252 | Dicoumarin | 253, 469 | 231 |
| 253 | Dicoumarol (INN) | 252, 469 | 231 |
| 254 | Diethanolamine | (110, 640) | 411 |
| 255 | 2-(Diethylaminoethoxy)ethyl α-phenylpiperidine-1-acetate dimethiodide | 598 | 137 |
| 256 | 2-Diethylaminoethyl 3-amino-4-butoxybenzoate and its salts | 101 | 23 |
| 257 | 2-Diethylaminoethyl benzilate | 72 | 157 |
| 258 | 2-Diethylaminoethyl 4-ethoxybenzoate and its salts | 410, 536 | 179 |
| 259 | 2-Diethylaminoethyl 3-hydroxy-4-phenylbenzoate and its salts | — | 128 |
| 260 | 2-Diethylaminoethyl phenyl(piperidino)acetate | 103 | 287 |
| 261 | 3-Diethylaminopropyl cinnamate | — | 130 |
| 262 | Diethyl 4-nitrophenyl phosphate | 534 | 170 |
| 263 | O,O-Diethyl O-4-nitrophenyl phosphorothioate | 535 | 131 |
| 264 | Difencloxazine (INN) | 566 | 270 |
| 265 | Digitaline and all heterosides of Digitalis purpurea L. | — | 134 |
| 266 | 4,5-Dihydrobenzimidazol-4-one | 86, 87 | 48 |
| 267 | 3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano[3,2-c]-[1]-benzopyran-5-one | 224 | 234 |
| 268 | Dihydrotachysterol (INN) | — | 342 |
| 269 | 3,4-Dihydroxy-α-(methylaminomethyl)benzyl alcohol | 14, 314 | 14 |
| 270 | 4,4'-Dihydroxy-3,3'-(3-methylthiopropylidene)dicoumarin | — | 207 |
| 271 | 1-(3,4-Dihydroxyphenyl)-2-ethylaminopropan-1-ol and its salts | 293 | 136 |
| 272 | 1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol | 417, 420 | 17 |
| 273 | Diisopropanolamine | (110, 640) | 411 |
| 274 | 5,5'-Di-isopropyl-2,2'-dimethylbiphenyl-4,4'-diyl dihypoiodite | 412 | 361 |
| 275 | Dimethoxane | 285 | 368 |
| 276 | 4-[2-(3,4-Dimethoxyphenyl)ethyl]-1-(2-chlorophenyl)piperazine and its salts | 438 | 141 |
| 277 | Dimethylamine | — | 142 |
| 278 | 2-Dimethylaminoethyl N-acetylglutamate | 233 | 3 |
| 279 | 2-Dimethylaminoethyl p-butylaminobenzoate and its salts | 687 | 63 |
| 280 | (+)-4-Dimethylamino-3-methyl-1,2-diphenyl-2-propionyloxybutane | 237 | 116 |
| 281 | 1-Dimethylaminomethyl-1-methylpropyl benzoate and its salts | 50 | 50 |
| 282 | 2-Dimethylaminopropiophenone and its salts | 445 | 145 |
| 283 | 3-(3-Dimethylaminopropylidene)-1,2:4,5-dibenzocyclohepta-1,4-diene and its salts | 42 | 146 |
| 284 | 1,1-Dimethylbiguanide and its salts | 447 | 147 |
| 285 | 2,6-Dimethyl-1,3-dioxan-4-yl acetate | 275 | 368 |
| 286 | Dimethylformamide | — | 355 |
| 287 | 1,5-Dimethylhexylamine and its salts | 34, 523 | 28 |
| 288 | 1,3-Dimethylpentylamine and its salts | 35, 471 | 30 |
| 289 | Dimethyl sulfoxide (INN) | — | 338 |
| 290 | Dimevamide (INN) and its salts | 297 | 153 |
| 291 | Dinitrophenol isomers | — | 151 |
| 292 | Dioxane | — | 343 |
| 293 | Dioxethedrin (INN) and its salts | 271 | 136 |
| 294 | 2,5-Dioxo-3,3-diethyl-5-methylpiperidine and its salts | 483 | 133 |
| 295 | Diphenhydramine (INN) and its salts | 81 | 339 |
| 296 | Diphenoxylate hydrochloride (INNM) | 220 | 80 |
| 297 | 2,2-Diphenyl-4-dimethylaminovaleramide and its salts | 290 | 153 |
| 298 | 5,5-Diphenyl-4-imidazolidone | — | 160 |
| 299 | 4-Diphenylmethoxy-1-methylpiperidine and its salts | 305 | 154 |
| 300 | 3-Diphenylmethoxytropane and its salts | 76 | 158 |
| 301 | 1-Diphenylmethyl-4-methylpiperazine and its salts | 222 | 159 |
| 302 | 1,2-Diphenyl-4-(2-phenylsulphinylethyl)-pyrazolidine-3,5-dione | 661 | 155 |
| 303 | α,α-Diphenyl-2-piperidinemethanol and its salts | 597 | 285 |
| 304 | α,α-Diphenyl-4-piperidinemethanol and its salts | 66 | 286 |
| 305 | Diphenylpyraline (INN) and its salts | 299 | 154 |
| 306 | 2,5-Dipropoxy-3,6-bis(ethyleneimino)-1,4-benzoquinone | 409 | 152 |
| 307 | 4-Dipropylsulphamoylbenzoic acid | 606 | 161 |
| 308 | Disulfiram (INN) | 699, 710 | 162 |
| 309 | Dithio-2,2'-bis(pyridine 1-oxide) 1,1' (additive with trihydrated magnesium sulphate) | 625 | 396 |
| 310 | Doxylamine (INN) and its salts | 576 | 176 |
| 311 | Emetine, its salts and derivatives | — | 163 |
| 312 | Endrin (ISO) | 372 | 196 |
| 313 | Ephedrine and its salts | — | 164 |
| 314 | Epinephrine (INN) | 14, 269 | 14 |
| 315 | 1,2-Epoxybutane | — | 400 |
| 316 | Ergocalciferol (INN) | 139, (759) | 335 |
| 317 | Ergot and its alkaloids | 193 | 98 |
| 318 | Eserine and its salts | 586 | 166 |
| 319 | Ethionamide (INN) | 335 | 319 |
| 320 | Ethoheptazine (INN) and its salts | 476 | 173 |
| 321 | Ethopropazine and its salts | (558) | 320 |
| 322 | 4-Ethoxyphenol | (390) | 178 |
| 323 | 4-Ethoxy-m-phenylenediamine and its salts | — | 406 |
| 324 | 2-Ethylamino-5-phenyloxazolin-4-one | 344 | 180 |
| 325 | Ethyl bis(4-hydroxycoumarinyl)acetate and salts of the acid | 326 | 204 |
| 326 | Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate and salts of the acid | 325 | 204 |
| 327 | Ethyl chloride | 167 | 96 |
| 328 | Ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate and its salts | 446 | 171 |
| 329 | Ethylene dichloride | (248) | 125 |
| 330 | Ethylene oxide | — | 182 |
| 331 | 2-Ethyl-2,3-epoxyhexamide and its derivatives | 528 | 165 |
| 332 | Ethyl p-fluorophenyl sulphone | 347 | 189 |
| 333 | Ethyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate and its salts | 530 | 172 |
| 334 | Ethylidene dichloride | (248) | 125 |
| 335 | 3-Ethylisothionicotinamide | 319 | 319 |
| 336 | 3-Ethyl-3-methylglutarimide and its salts | 71, 337 | 183 |
| 337 | 4-Ethyl-4-methylpiperidine-2,6-dione and its salts | 71, 336 | 183 |
| 338 | 2-Ethyl-3-methylvaleramide | 753 | 184 |
| 339 | Ethylphenacemide | 553, 565 | 272 |
| 340 | 2-Ethyl-2-phenylglutarimide and its salts | 361 | 181 |
| 341 | 3'-Ethyl-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-2'-acetonaphthone | 9 | 362 |
| 342 | Ethyl urocanate | (405) | 418 |
| 343 | Fenadiazole (INN) | 526 | 208 |
| 344 | Fenozolone (INN) | 324 | 180 |
| 345 | Fenyramidol (INN) | 575, 579 | 274 |
| 346 | Fluanisone (INN) | 350 | 187 |
| 347 | Fluoresone (INN) | 332 | 189 |
| 348 | 4'-Fluoro-4-[4-hydroxy-4-(α,α,α-trifluoro-m-tolyl)piperino]butyrophenone | 738 | 188 |
| 349 | 6-Fluoro-16-methyl-11β,17α,21-trihydroxypregna-1,4-diene-3,20-dione | 533 | 186 |
| 350 | 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]butan-1-one | 346 | 187 |
| 351 | 5-Fluoropyrimidine-2,4-dione | 352 | 190 |
| 352 | Fluorouracil (INN) | 351 | 190 |
| 353 | Fluphenazine (INN) | (558) | 320 |
| 354 | Furazolidone (INN) | 511 | 252 |
| 355 | Furfuryltrimethylammonium salts | 357 | 192 |
| 356 | Furocoumarins (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | 98, 462, 620, 743 | 358 |
| 357 | Furtrethonium iodide (INN) | (355) | 192 |
| 358 | Galantamine (INN) | — | 193 |
| 359 | Gallamine triethiodide (INN) | 516 | 329 |
| 360 | Glucocorticoids | 100 | 300 |
| 361 | Glutethimide (INN) and its salts | 340 | 181 |
| 362 | Glycerol trinitrate | 512, 612 | 253 |
| 363 | Glycyclamide (INN) | 227 | 100 |
| 364 | Gold salts | — | 296 |
| 365 | Guaifenesin (INN) | 459 | 230 |
| 366 | Guanethidine (INN) and its salts | 367 | 259 |
| 367 | N-(2-Guanidinoethyl)azocane and its salts | 366 | 259 |
| 368 | Haloperidol (INN) | 173 | 185 |
| 369 | HCH (ISO) (gamma-HCH) | 102, 371, 428 | 195 |
| 370 | HETP | 377 | 316 |
| 371 | 1,2,3,4,5,6-Hexachlorocyclohexane | 102, 369, 428 | 195 |
| 372 | (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene | 312 | 196 |
| 373 | Hexachloroethane | — | 197 |
| 374 | 3,3',4,4',6,6'-Hexachloro-2,2'-methylenediphenol | 375 | 371 |
| 375 | Hexachlorophene (INN) | 374 | 371 |
| 376 | (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene | 415 | 198 |
| 377 | Hexaethyl tetraphosphate | 370 | 316 |
| 378 | (1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride | 141 | 70 |
| 379 | (3S,5aR,9bS)-3,3a,4,5,5a,9b-Hexahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8-dione | 636 | 217 |
| 380 | Hexamethonium bromide (INN) | (381) | 124 |
| 381 | N,N'-Hexamethylenebis(trimethylammonium) salts | 380 | 124 |
| 382 | Hexapropymate (INN) | 616 | 115 |
| 383 | Hydrastine, hydrastinine and their salts | — | 199 |
| 384 | Hydrazides and their salts | — | 200 |
| 385 | Hydrazine, its derivatives and their salts | — | 201 |
| 386 | 2-Hydrazino-octane and its salts | 521 | 202 |
| 387 | Hydrocyanic acid and its salts | 389, 408, 601, 642 | 111 |
| 388 | Hydrofluoric acid, its normal salts, complexes and hydrofluorides (except those listed in Part I of Schedule 2) | — | 191 |
| 389 | Hydrogen cyanide and its salts | 387, 408, 601, 642 | 111 |
| 390 | Hydroquinone monobenzyl, monoethyl and monomethyl ethers | 96, 322, 458, 487 | 178 |
| 391 | 7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline | 762 | 135 |
| 392 | [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid and its salts | 739 | 5 |
| 393 | 3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propionic acid and its salts | 713 | 9 |
| 394 | 2-Hydroxy-3-(2-methoxyphenyl)propyl carbamate | 450 | 205 |
| 395 | 1-Hydroxymethyl-1-cyclohexylacetic acid, sodium salt | 643 | 114 |
| 396 | 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]coumarin | 1 | 254 |
| 397 | 8-Hydroxy-5-nitroquinoline and its salts | 515 | 209 |
| 398 | 4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin and its salts | 3, 760 | 203 |
| 399 | 11α-Hydroxypregn-4-ene-3,20-dione and its esters | — | 385 |
| 400 | Hydroxy-8-quinoline and its sulphate, except for the uses provided for in entry number 51 in Part I of Schedule 2 | 114, 531, 630 | 395 |
| 401 | Hydroxyzine (INN) | 171 | 240 |
| 402 | Hyoscine, its salts and derivatives | 638 | 295 |
| 403 | Hyoscyamine, its salts and derivatives | — | 210 |
| 404 | Hyoscyamus niger L.(leaves, seeds, powder and galenical preparations) | — | 211 |
| 405 | 3-Imidazol-4-ylacrylic acid and its ethyl ester | 342, 751 | 418 |
| 406 | 2-Imino-5-phenyloxazolidin-4-one and its salts | 538 | 212 |
| 407 | Imperatorin | 465 | 34 |
| 408 | Inorganic cyanides | (387, 389) 601, 642 | 111 |
| 409 | Inproquone (INN) | 306 | 152 |
| 410 | Intracaine and its salts | 258, 536 | 179 |
| 411 | Iodine | — | 213 |
| 412 | Iodothymol | 274 | 361 |
| 413 | Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations) | — | 215 |
| 414 | Isocarboxazid (INN) | 93 | 52 |
| 415 | Isodrin | 376 | 198 |
| 416 | Isometheptene (INN) and its salts | 463 | 228 |
| 417 | Isoprenaline (INN) | 272, 420 | 17 |
| 418 | Isopropamide iodide (INN) | (145) | 156 |
| 419 | (2-Isopropylpent-4-enoyl)urea | 60 | 216 |
| 420 | Isoproterenol | 272, 417 | 17 |
| 421 | Isosorbide dinitrate (INN) | 244 | 148 |
| 422 | Juniperus sabina L. (leaves, essential oil and galenical preparations) | — | 294 |
| 423 | Laurel oil | 424 | 359 |
| 424 | Laurus nobilis L. (oil from seeds) | 423 | 359 |
| 425 | Lead and its compounds (except lead acetate subject to the restrictions laid down in entry number 55 in Part I of Schedule 2) | — | 289 |
| 426 | Levophacetoperane and its salts | 594 | 284 |
| 427 | Lidocaine (INN) (Lignocaine) | — | 399 |
| 428 | Lindane | 102, 369, 371 | 195 |
| 429 | Lobelia inflata L. and its galenical preparations | — | 218 |
| 430 | Lobeline (INN) and its salts | 112 | 219 |
| 431 | LSD | (433, 434) | 127 |
| 432 | Lupinidine and its salts | 648 | 299 |
| 433 | Lysergic acid diethylamide and its salts | 431, 434 | 127 |
| 434 | Lysergide (INN) and its salts | 431, 433 | 127 |
| 435 | Malononitrile | — | 149 |
| 436 | Mannomustine (INN) and its salts | 104 | 89 |
| 437 | Mecamylamine (INN) | 698 | 229 |
| 438 | Mefeclorazine (INN) and its salts | 276 | 141 |
| 439 | Mephenesin (INN) and its esters | 718 | 322 |
| 440 | Meprobamate (INN) | 481 | 236 |
| 441 | Mercury and its compounds (except those listed in Part I of Schedule 4) | — | 221 |
| 442 | Mescaline and its salts | 740 | 222 |
| 443 | Metabromsalan (INN) | (246) | 351 |
| 444 | Metaldehyde | 600 | 223 |
| 445 | Metamfepramone (INN) and its salts | 282 | 145 |
| 446 | Metethoheptazine (INN) and its salts | 328 | 171 |
| 447 | Metformin (INN) and its salts | 284 | 147 |
| 448 | Methapyrilene (INN) and its salts | 624 | 144 |
| 449 | Metheptazine (INN) and its salts | 468 | 174 |
| 450 | Methocarbamol (INN) | 394 | 205 |
| 451 | Methohexitone and its salts | (69) | 220 |
| 452 | Methotrexate (INN) | 33 | 6 |
| 453 | 2-[4-Methoxybenzyl-N-(2-pyridyl)amino]-ethyldimethylamine maleate | 622 | 346 |
| 454 | 1-Methoxy-2,2-bis(4-hydroxy-3-coumarinyl)ethane | 215 | 225 |
| 455 | 1-Methoxy-2,4-diaminobenzene and its salts | 239, 461 | 376 |
| 456 | 1-Methoxy-2,5-diaminobenzene and its salts | 240, 460 | 377 |
| 457 | (+)-3-Methoxy-N-methylmorphinan and its salts | 236 | 226 |
| 458 | 4-Methoxyphenol | (390) | 178 |
| 459 | 3-(2-Methoxyphenoxy)propane-1,2-diol | 365 | 230 |
| 460 | 2-Methoxy-p-phenylenediamine and its salts | 240, 456 | 377 |
| 461 | 4-Methoxy-m-phenylenediamine and its salts | 239, 455 | 376 |
| 462 | Methoxypsoralens (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (356) | 358 |
| 463 | 6-Methylamino-2-methylhept-2-ene and its salts | 416 | 228 |
| 464 | 2-Methyl-1,2-bis(3-pyridyl)propan-1-one | 484 | 292 |
| 465 | 9-(3-Methylbut-2-enyloxy)furo-[3,2-g]chromen-7-one | 407 | 34 |
| 466 | 2-Methyl-6-chloroanilide of n-butylaminoacetic acid and its salts | 125 | 90 |
| 467 | 1-Methyl-2,4-diaminobenzene and its salts | 477 | 364 |
| 468 | Methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate and its salts | 449 | 174 |
| 469 | 3,3-Methylenebis-(4-hydroxycoumarin) | 252, 253 | 231 |
| 470 | 2-Methylheptylamine and its salts | — | 227 |
| 471 | 4-Methyl-2-hexylamine and its salts | 35, 288 | 30 |
| 472 | 1-Methylimidazole-2-thiol | 474, 704 | 233 |
| 473 | N-N'-[(Methylimino)diethylene]bis-(ethyldimethylammonium) salts | 67 | 121 |
| 474 | 1-Methyl-2-mercaptoimidazole | 472, 704 | 233 |
| 475 | Methylphenidate (INN) and its salts | 572 | 175 |
| 476 | 1-Methyl-4-phenyl-4-carbethoxyhexa-methyleneimine and its salts | 320 | 173 |
| 477 | 4-Methyl-m-phenylenediamine and its salts | 467 | 364 |
| 478 | 2-Methyl-m-phenylenediamine | — | 413 |
| 479 | 3-Methyl-2-phenylmorpholine, its derivatives and salts | 555 | 232 |
| 480 | 2-Methyl-2-propyl-1-isopropylcarbamoyloxy-3-carbamoyloxypropane | 151 | 235 |
| 481 | 2-Methyl-2-propyltrimethylene dicarbamate | 440 | 236 |
| 482 | N-Methyl-1,2,5,6-tetrahydro-3-nicotinic acid methyl ester | 61 | 238 |
| 483 | Methyprylon (INN) and its salts | 294 | 133 |
| 484 | Metyrapone (INN) | 464 | 292 |
| 485 | Minoxidil (INN), its salts and derivatives | 596 | 372 |
| 486 | Mofebutazone (INN) | 133 | 64 |
| 487 | Monobenzone (INN) | 96, (390) | 178 |
| 488 | Morpholine and its salts | — | 344 |
| 489 | Musk ambrette | 132 | 414 |
| 490 | Mustine and its salts | 106, 160 | 87 |
| 491 | Mustine N-oxide and its salts | 107 | 86 |
| 492 | Nalorphine (INN), its salts and ethers | 21 | 20 |
| 493 | Naphazoline (INN) and its salts | 499 | 244 |
| 494 | 2-Naphthol | 495 | 241 |
| 495 | β-Naphthol | 494 | 241 |
| 496 | 1- and 2-Naphthylamines and their salts | 497 | 242 |
| 497 | α- and β-Naphthylamines and their salts | 496 | 242 |
| 498 | 3-(1-Naphthyl)-4-hydroxycoumarin | — | 243 |
| 499 | 2-(1-Naphthylmethyl)-2-imidazoline and its salts | 493 | 244 |
| 500 | Narcotics, natural and synthetic: All substances listed in Tables I and II of the Single Convention on Narcotic Drugs 1961 (Treaty Series No. 34 (1965), Cmnd. 2631) | — | 306 |
| 501 | Narcotine and its salts | 519 | 258 |
| 502 | Neodymium and its salts | — | 309 |
| 503 | Neostigmine and its salts | — | 245 |
| 504 | Nicotine and its salts | — | 246 |
| 505 | Nitrites, inorganic (except sodium nitrite) | — | 248 |
| 506 | Nitrobenzene | — | 249 |
| 507 | Nitrocresols and their alkali metal salts | — | 250 |
| 508 | Nitroderivatives of carbazole | 146 | 72 |
| 509 | Nitrofurantoin (INN) | 510 | 251 |
| 510 | N-(5-Nitro-2-furfurylidene)-1-aminohydantoin | 509 | 251 |
| 511 | 3-(5-Nitrofurfurylideneamino)oxazolidin-2-one | 354 | 252 |
| 512 | Nitroglycerine | 362, 612 | 253 |
| 513 | Nitrosamines | — | 410 |
| 514 | Nitrostilbenes, their homologues and derivatives | — | 256 |
| 515 | Nitroxoline (INN) and its salts | 397 | 209 |
| 516 | N,N,N,N',N',N',N",N",N"-Nonaethyl-2,2',2"-(benzene-1,2,3-triyltrioxy)-tris(ethanaminium) triiodide | 359 | 329 |
| 517 | Noradrenaline and its salts | 32, 518 | 257 |
| 518 | Norepinephrine (INN) and its salts | 32, 517 | 257 |
| 519 | Noscapine (INN) and its salts | 501 | 258 |
| 520 | Nux vomica and its preparations | (658) | 305 |
| 521 | Octamoxin (INN) and its salts | 386 | 202 |
| 522 | Octamylamine (INN) and its salts | — | 267 |
| 523 | Octodrine (INN) and its salts | 34, 287 | 28 |
| 524 | Oestrogens | — | 260 |
| 525 | Oleandrin | — | 261 |
| 526 | 2-(1,3,4-Oxadiazol-2-yl)phenol | 343 | 208 |
| 527 | [Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts | 24 | 132 |
| 528 | Oxanamide (INN) and its derivatives | 331 | 165 |
| 529 | 2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine and its salts | 685 | 139 |
| 530 | Oxpheneridine (INN) and its salts | 333 | 172 |
| 531 | Oxyquinoline and its sulphate, except for the uses provided for in entry number 51 in Part I of Schedule 2 | 114, 400, 630 | 395 |
| 532 | Padimate A | 47 | 381 |
| 533 | Paramethasone (INN) | 349 | 186 |
| 534 | Paraoxon | 262 | 170 |
| 535 | Parathion (ISO) | 263 | 131 |
| 536 | Parethoxycaine (INN) and its salts | 258, 410 | 179 |
| 537 | Pelletierine and its salts | 595 | 263 |
| 538 | Pemoline (INN) and its salts | 406 | 212 |
| 539 | Pentachloroethane | — | 264 |
| 540 | Pentaerythritol chloral | 549 | 266 |
| 541 | Pentaerythritol tetranitrate | 542, 548 | 265 |
| 542 | Pentaerythrityl tetranitrate (INN) | 541, 548 | 265 |
| 543 | Pentamethonium bromide (INN) | (544) | 120 |
| 544 | N,N'-Pentamethylenebis(trimethyl-ammonium) salts | 543 | 120 |
| 545 | Pentobarbitone and its salts | (69) | 220 |
| 546 | Perchloroethylene | 689 | 314 |
| 547 | Perphenazine (INN) and its salts | (558) | 320 |
| 548 | PETN | 541, 542 | 265 |
| 549 | Petrichloral (INN) | 540 | 266 |
| 550 | Phenacemide (INN) | 561 | 269 |
| 551 | Phenaglycodol (INN) | 174 | 95 |
| 552 | Phenetamine | 225 | 112 |
| 553 | Pheneturide (INN) | 339, 565 | 272 |
| 554 | Phenindone (INN) | 571 | 271 |
| 555 | Phenmetrazine (INN), its derivatives and salts | 479 | 232 |
| 556 | Phenobarbitone and its salts | (69) | 220 |
| 557 | Phenolphthalein (INN) | 113 | 417 |
| 558 | Phenothiazine (INN) and its compounds | various | 320 |
| 559 | Phenprobamate (INN) | 573 | 71 |
| 560 | Phenprocoumon (INN) | 574 | 273 |
| 561 | N-Phenylacetylurea | 550 | 269 |
| 562 | 4-Phenylazophenylene-1,3-diamine citrate hydrochloride | 190 | 81 |
| 563 | Phenylbutazone (INN) | 131 | 67 |
| 564 | 4-Phenylbut-3-en-2-one | 94 | 356 |
| 565 | (2-Phenylbutyryl)urea | 339, 553 | 272 |
| 566 | N-[2-(α-Phenyl-p-chlorobenzyl)-ethyl]morpholine | 264 | 270 |
| 567 | 1-Phenylcyclopentanecarboxylic acid diethylaminoethyl ester and its salts | 144 | 169 |
| 568 | 2-Phenylcyclopropylamine (trans-form) and its salts | 719 | 324 |
| 569 | 1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one | 617 | 138 |
| 570 | o-Phenylenediamine and its salts | 241 | 363 |
| 571 | 2-Phenylindan-1,3-dione | 554 | 271 |
| 572 | α-Phenyl-2-piperidineacetic acid methyl ester and its salts | 475 | 175 |
| 573 | 3-Phenylpropyl carbamate | 559 | 71 |
| 574 | 3-(α-Phenylpropyl)-4-hydroxycoumarin | 560 | 273 |
| 575 | 1-Phenyl-2-(2-pyridylamino)ethanol | 345, 579 | 274 |
| 576 | 2-[1-Phenyl-1-(2-pyridyl)ethoxy]-ethyldimethylamine and its salts | 310 | 176 |
| 577 | 2-Phenylquinoline-4-carboxylic acid, its salts and derivatives and salts of those derivatives | 192 | 8 |
| 578 | 6-Phenyl-2,4,7-triaminopteridine and its salts | 722 | 275 |
| 579 | Phenyramidol | 345, 575 | 274 |
| 580 | Phosphides, metal | — | 279 |
| 581 | Phosphorus | — | 279 |
| 582 | 4-Phosphoryloxy-N,N-dimethyltryptamine | 619 | 278 |
| 583 | 3-Phthalimidopiperidine-2,6-dione and its salts | 701 | 280 |
| 584 | Phthalylsulphathiazole (INN) and its salts | (675) | 307 |
| 585 | Physostigma venenosum Balf. | 138 | 281 |
| 586 | Physostigmine and its salts | 318 | 166 |
| 587 | Phytolacca Spp and their preparations | — | 374 |
| 588 | Picric acid | 742 | 268 |
| 589 | Picrotoxin | 197 | 282 |
| 590 | Pilocarpine and its salts | — | 283 |
| 591 | Pilocarpus jaborandi Holmes and its galenical preparations | — | 311 |
| 592 | Pipazetate (INN) and its salts | 593 | 118 |
| 593 | 2-(2-Piperidinoethoxy)ethyl 10-thia-1,9-diazaanthracene-9-carboxylate and its salts | 592 | 118 |
| 594 | α-Piperidin-2-ylbenzyl acetate, laevorotatory threo-form and its salts | 426 | 284 |
| 595 | 1-(2-Piperidyl)propan-2-one and its salts | 537 | 263 |
| 596 | 6-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide, its salts and derivatives | 485 | 372 |
| 597 | Pipradrol (INN) and its salts | 303 | 285 |
| 598 | Piprocurarium iodide (INN) | 255 | 137 |
| 599 | Poldine metilsulfate (INN) (Poldine methylsulphate) | 85 | 239 |
| 600 | Polyacetaldehyde | 444 | 223 |
| 601 | Potassium cyanide | (387, 389, 408) | 111 |
| 602 | Potassium nitroferricyanide | (15), 603 | 255 |
| 603 | Potassium nitroprusside | (15), 602 | 255 |
| 604 | Pramocaine (INN) | 605 | 405 |
| 605 | Pramoxine | 604 | 405 |
| 606 | Probenecid (INN) | 307 | 161 |
| 607 | Procainamide (INN), its salts and derivatives | 29 | 25 |
| 608 | Prochlorperazine (INN) and its salts | (558) | 320 |
| 609 | Progestogens | — | 194 |
| 610 | Promazine (INN) and its salts | (558) | 320 |
| 611 | Promethazine (INN) and its salts | (558) | 320 |
| 612 | Propane-1,2,3-triyl trinitrate | 362, 512 | 253 |
| 613 | Propatylnitrate (INN) | 111 | 206 |
| 614 | 1-Propyl-3-(4-chlorobenzenesulphonyl)urea | 182 | 79 |
| 615 | 2-Propylpiperidine | 212 | 290 |
| 616 | 1-(2-Propynyl)cyclohexyl carbamate | 382 | 115 |
| 617 | Propyphenazone (INN) | 569 | 138 |
| 618 | Prunus laurocerasus L. | 157 | 291 |
| 619 | Psilocybine (INN) | 582 | 278 |
| 620 | Psoralen (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (356) | 358 |
| 621 | Pyrethrum album L. and its galenical preparations | — | 345 |
| 622 | Pyrianisamine maleate | 453 | 346 |
| 623 | Pyribenzamine | 97, 745 | 347 |
| 624 | 2-(N-2-Pyridyl-N-2-thienylamino)ethyl-dimethylamine and its salts | 448 | 144 |
| 625 | Pyrithione disulphide+magnesium sulphate | 309 | 396 |
| 626 | Pyrithione sodium (INNM) | — | 369 |
| 627 | Pyrocatechol | 79, 153 | 408 |
| 628 | Pyrogallol | — | 409 |
| 629 | Quinalbarbitone and its salts | (69) | 220 |
| 630 | Quinolin-8-ol except for the uses provided for in entry number 51 in Part I of Schedule 2 | (400, 531) | 395 |
| 631 | Radioactive substances (except substances which are radioactive naturally or by reason of contamination from the environment, which have not been enriched for manufacturing purposes, and of which the concentration complies with Council Directive No. 76/579/Euratom[^f00038]) | — | 293 |
| 632 | Rauwolfia serpentina alkaloids and their salts | 633 | 15 |
| 633 | Reserpine (INN) and its salts | (632) | 15 |
| 634 | Retinoic acid and its salts | 721, 758 | 375 |
| 635 | Safrole (except natural content of essences in cases where the concentration of such safrole in the cosmetic product does not exceed— in the case of oral hygiene or dental products other than toothpaste intended specifically for children, 50 mg/kg; or in the case of products other than oral hygiene or dental products, 100 mg/kg) | — | 360 |
| 636 | α-Santonin | 379 | 214 |
| 637 | Schoenocaulon officinale Lind. (seeds and galenical preparations) | — | 332 |
| 638 | Scopolamine, its salts and derivatives | 402 | 295 |
| 639 | Secbutobarbitone and its salts | (69) | 220 |
| 640 | Secondary dialkanolamines | 110, 254, 273 | 411 |
| 641 | Selenium and its compounds except when permitted under the restrictions laid down in Part I of Schedule 2 | — | 297 |
| 642 | Sodium cyanide | (387, 389, 408) | 111 |
| 643 | Sodium hexacyclonate (INN) | 395 | 114 |
| 644 | Sodium nitroferricyanide | (15), 645 | 255 |
| 645 | Sodium nitroprusside | (15), 644 | 255 |
| 646 | Solanum nigrum L. and its galenical preparations | — | 298 |
| 647 | Spanish Fly | 140 | 69 |
| 648 | Sparteine (INN) and its salts | 432 | 299 |
| 649 | Spironolactone (INN) | 10 | 4 |
| 650 | Squill and its preparations | 750 | 330 |
| 651 | Stramonium and its preparations | 231 | 301 |
| 652 | Strontium lactate | — | 402 |
| 653 | Strontium nitrate | — | 403 |
| 654 | Strontium polycarboxylate | — | 404 |
| 655 | Strophanthines and their aglucones and their respective derivatives | — | 302 |
| 656 | Strophanthus species and their galenical preparations | — | 303 |
| 657 | Strychnine and its salts | — | 304 |
| 658 | Strychnos species and their galenical preparations | 520 | 305 |
| 659 | Succinonitrile | — | 150 |
| 660 | Succinylsulphathiazole and its salts | (675) | 307 |
| 661 | Sulfinpyrazone (INN) | 302 | 155 |
| 662 | Sulphacetamide and its salts | (675) | 307 |
| 663 | Sulphadiazine and its salts | (675) | 307 |
| 664 | Sulphadimethoxine and its salts | (675) | 307 |
| 665 | Sulphadimidine and its salts | (675) | 307 |
| 666 | Sulphafurazole and its salts | (675) | 307 |
| 667 | Sulphaguanidine and its salts | (675) | 307 |
| 668 | Sulphamethizole and its salts | (675) | 307 |
| 669 | Sulphamethoxazole and its salts | (675) | 307 |
| 670 | Sulphamethoxydiazine and its salts | (675) | 307 |
| 671 | Sulphamethoxypyridazine and its salts | (675) | 307 |
| 672 | Sulphanilamide and its salts | (675) | 307 |
| 673 | Sulphapyridine and its salts | (675) | 307 |
| 674 | Sulphathiazole and its salts | (675) | 307 |
| 675 | Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the −NH₂ groups) and their salts | 584, 660, 662–674 | 307 |
| 676 | Sulthiame | 677, 696 | 308 |
| 677 | Sultiame (INN) | 676, 696 | 308 |
| 678 | Sympathomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe | 44 | 21 |
| 679 | Tefazoline (INN) and its salts | 695 | 237 |
| 680 | Tellurium and its compounds | — | 312 |
| 681 | TEPP (ISO) | 693 | 276 |
| 682 | 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline and its salts | 764 | 313 |
| 683 | 4-tert-Butylphenol | — | 340 |
| 684 | 4-tert-Butylpyrocatechol | — | 341 |
| 685 | Tetrabenazine (INN) and its salts | 529 | 139 |
| 686 | Tetrabromosalicylanilides | — | 350 |
| 687 | Tetracaine (INN) and its salts | 279 | 63 |
| 688 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin | — | 367 |
| 689 | Tetrachloroethylene | 546 | 314 |
| 690 | Tetrachloromethane | 148 | 315 |
| 691 | Tetrachlorosalicylanilides | — | 348 |
| 692 | Tetraethylammonium bromide | 700 | 61 |
| 693 | Tetraethyl pyrophosphate | 681 | 276 |
| 694 | (R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol and its salts | 59 | 42 |
| 695 | 2-(5,6,7,8-Tetrahydro-1-naphthylmethyl)-2-imidazoline and its salts | 679 | 237 |
| 696 | 4-(Tetrahydro-2H-1,2-thiazin-2-yl)-benzenesulphonamide S,S-dioxide | 676, 677 | 308 |
| 697 | Tetrahydrozoline and its salts | — | 394 |
| 698 | N,2,3,3-Tetramethyl-2-norcamphanamine | 437 | 229 |
| 699 | Tetramethylthiuram disulphide | 710 | 162 |
| 700 | Tetrylammonium bromide (INN) | 692 | 61 |
| 701 | Thalidomide (INN) and its salts | 583 | 280 |
| 702 | Thallium and its compounds | — | 317 |
| 703 | Thevetia neriifolia Juss., glycoside extract | — | 318 |
| 704 | Thiamazole (INN) | 472, 474 | 233 |
| 705 | 2,2'-Thiobis(4,6-dichlorophenol) | 115 | 352 |
| 706 | Thiopentone and its salts | (69) | 220 |
| 707 | Thioridazine (INN) and its salts | (558) | 320 |
| 708 | Thiotepa (INN) | 723 | 310 |
| 709 | Thiourea and its derivatives (except those listed in Part I of Schedule 2) | — | 321 |
| 710 | Thiram (ISO) | 699 | 162 |
| 711 | Thiuram disulphides | — | 354 |
| 712 | Thiuram monosulphides | — | 353 |
| 713 | Thyropropic acid (INN) and its salts | 393 | 9 |
| 714 | Tolboxane (INN) | 717 | 177 |
| 715 | Tolbutamide (INN) | 134 | 65 |
| 716 | Toluidines, their isomers, salts and halogenated and sulphonated derivatives | 40 | 32 |
| 717 | p-Tolylboric acid ester of 2-methyl-2-propylpropane-1,3-diol | 714 | 177 |
| 718 | 3-o-Tolyloxypropane-1,2-diol | (439) | 322 |
| 719 | Tranylcypromine (INN) and its salts | 568 | 324 |
| 720 | Tretamine (INN) | 724 | 328 |
| 721 | Tretinoin (INN) and its salts | 634, 758 | 375 |
| 722 | Triamterene (INN) and its salts | 578 | 275 |
| 723 | Tri(aziridin-1-yl)phosphine sulphide | 708 | 310 |
| 724 | 2,4,6-Tri(aziridin-1-yl)-1,3-triazine | 720 | 328 |
| 725 | 2,2,2-Tribromoethanol | (726) | 326 |
| 726 | Tribromoethyl alcohol | 725 | 326 |
| 727 | Tribromsalan (INN) | 728 | 373 |
| 728 | 3,4',5-Tribromosalicylanilide | 727 | 373 |
| 729 | Trichlormethine (INN) and its salts | 746 | 327 |
| 730 | Trichloroacetic acid | — | 10 |
| 731 | 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane | 195, 232 | 123 |
| 732 | 2,2,2-Trichloroethane-1,1-diol | 158 | 77 |
| 733 | Trichloromethane | 168 | 366 |
| 734 | N-(Trichloromethylthio)cyclohex-4-ene-1,2-dicarboximide | 142 | 370 |
| 735 | Trichloronitromethane | 178 | 325 |
| 736 | Tricresyl phosphate | 747 | 277 |
| 737 | Trifluoperazine (INN) and its salts | (558) | 320 |
| 738 | Trifluperidol (INN) | 348 | 188 |
| 739 | 3,3',5-Triiodothyroacetic acid and its salts | 392 | 5 |
| 740 | 3,4,5-Trimethoxyphenethylamine and its salts | 442 | 222 |
| 741 | 2,2,6-Trimethyl-4-piperidyl benzoate and its salts | 75 | 51 |
| 742 | 2,4,6-Trinitrophenol | 588 | 268 |
| 743 | Trioxysalen (INN) (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (356) | 358 |
| 744 | Triparanol (INN) | 172 | 92 |
| 745 | Tripelennamine (INN) | 97, 623 | 347 |
| 746 | Tris(2-chloroethyl)amine | 729 | 327 |
| 747 | Tritolyl phosphate | 736 | 277 |
| 748 | Tuaminoheptane (INN), its isomers and salts | 30 | 27 |
| 749 | Tyrothricin (INN) | — | 392 |
| 750 | Urginea scilla Stern. and its galenical preparations | 650 | 330 |
| 751 | Urocanic acid | (405) | 418 |
| 752 | Vaccines, toxins and serums listed in the Annex to Council Directive No. 75/319/EEC[^f00039] | — | 323 |
| 753 | Valnoctamide (INN) | 338 | 184 |
| 754 | Veratrine, its salts and galenical preparations | — | 331 |
| 755 | Veratrum spp and their preparations | — | 333 |
| 756 | Vinyl chloride monomer | — | 334 |
| 757 | Vinylidene chloride | (7, 249) | 126 |
| 758 | Vitamin A acid and its salts | 634, 721 | 375 |
| 759 | Vitamins D₂ and D₃ | 139, 187, 316 | 335 |
| 760 | Warfarin (ISO) and its salts | 3, 398 | 203 |
| 761 | Xanthates | 16 | 336 |
| 762 | Xanthinol | 391 | 135 |
| 763 | Xylidines, their isomers, salts and halogenated and sulphonated derivatives | 41 | 33 |
| 764 | Xylometazoline (INN) and its salts | 682 | 313 |
| 765 | Yohimbine and its salts | — | 337 |
| 766 | Zirconium and its compounds (except aluminium zirconium chloride hydroxide complexes and aluminium zirconium chloride hydroxide glycine complexes under the conditions laid down in Part I of Schedule 2 and zirconium lakes, salts and pigments prepared from those colouring agents identified in column 1 of Part I of Schedule 3 by “*” immediately after the name or colour index number) | — | 391 |
| 767 | Zoxazolamine (INN) | 28 | 24 |
SCHEDULE 2 — LIST OF SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN EXCEPT SUBJECT TO RESTRICTIONS
In this Schedule, the matters specified in columns 3, 4, 5 and 6 which apply to a particular substance are those set out to the right of its name as mentioned in column 2; and the matters specified in columns 4, 5 and 6 which apply in any particular case are those set out to the right of the matter specified in column 3 which applies in that case. The substance may not be used except for the purposes or contained other than in the types of product specified in column 3. The concentration of the substance in a product may not exceed the limit specified in column 4: where the names of two or more substances are mentioned in a single item as set out in column 2 and a product contains more than one of those substances, the limit specified in column 4 is the limit for all of those substances taken together; and where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall be calculated by reference to the mixture. Other requirements are specified in column 5. In column 4 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
Names which appear in square brackets in column 2 are the International Nomenclature Cosmetic Ingredient names of the substances in question given in the inventory of ingredients employed in cosmetic products drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC[^f00040].
PART I — SUBSTANCES LISTED IN ANNEX III, PART I OF THE DIRECTIVE AS SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN EXCEPT SUBJECT TO THE RESTRICTIONS LAID DOWN
| (1) | (2) | (3) | (4) | (5) | (6) |
|---|---|---|---|---|---|
| Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information |
| Note 1: Entry 15a is substituted with effect from the dates specified in regulation 1(6). Until then, entry number 15 in Part I of Schedule 2 to S.I. 1989/2233 continues in force. Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as percentage of sodium hydroxide. In cases of mixtures, the sum must not exceed the limits given in column (4). | Note 1: Entry 15a is substituted with effect from the dates specified in regulation 1(6). Until then, entry number 15 in Part I of Schedule 2 to S.I. 1989/2233 continues in force. Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as percentage of sodium hydroxide. In cases of mixtures, the sum must not exceed the limits given in column (4). | Note 1: Entry 15a is substituted with effect from the dates specified in regulation 1(6). Until then, entry number 15 in Part I of Schedule 2 to S.I. 1989/2233 continues in force. Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as percentage of sodium hydroxide. In cases of mixtures, the sum must not exceed the limits given in column (4). | Note 1: Entry 15a is substituted with effect from the dates specified in regulation 1(6). Until then, entry number 15 in Part I of Schedule 2 to S.I. 1989/2233 continues in force. Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as percentage of sodium hydroxide. In cases of mixtures, the sum must not exceed the limits given in column (4). | Note 1: Entry 15a is substituted with effect from the dates specified in regulation 1(6). Until then, entry number 15 in Part I of Schedule 2 to S.I. 1989/2233 continues in force. Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as percentage of sodium hydroxide. In cases of mixtures, the sum must not exceed the limits given in column (4). | Note 1: Entry 15a is substituted with effect from the dates specified in regulation 1(6). Until then, entry number 15 in Part I of Schedule 2 to S.I. 1989/2233 continues in force. Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as percentage of sodium hydroxide. In cases of mixtures, the sum must not exceed the limits given in column (4). |
| 1 | Boric acid | Talcum powder | 5 per cent | Not to be used in products intended for children less than three years old | Not to be used for children under three years of age |
| Oral hygiene products | 0.5 per cent | — | — | ||
| Other products | 3 per cent | — | — | ||
| 2a | Thioglycolic acid and its salts | (a) Hair waving or straightening products for general use | 8 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children |
| (b) Hair waving or straightening products for professional use | 11 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children. For professional use only | ||
| (c) Depilatories | 5 per cent ready for use | pH 7 to 12.7 | Contains thioglycolate. Follow the instructions. Keep out of reach of children | ||
| (d) Other hair-care products which are removed after application | 2 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children | ||
| The abovementioned percentages are calculated as thioglycolic acid | (a), (b), (c) and (d): The directions for use must incorporate the following: Avoid contact with eyes In the event of contact with eyes, rinse immediately with plenty of water and seek medical advice Wear suitable gloves ((a), (b) and (d) only) | ||||
| 2b | Thioglycolic acid esters | (a) Hair waving or straightening products for general use | 8 per cent ready for use | pH 6 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children |
| (b) Hair waving or straightening products for professional use | 11 per cent ready for use | pH 6 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children. For professional use only | ||
| The abovementioned percentages are calculated as thioglycolic acid | (a) and (b): the directions for use must incorporate the following: May cause sensitization in the event of skin contact Avoid contact with eyes In the event of contact with eyes, rinse immediately with plenty of water and seek medical advice Wear suitable gloves | ||||
| 3 | Oxalic acid, its esters and alkaline salts | Hair care products | 5 per cent | — | For professional use only |
| 4 | Ammonia | All purposes and products | 6 per cent calculated as NH₃ | — | Contains ammonia (not required when concentration is not more than 2 per cent) |
| 5 | Tosylchloramide sodium (INN) [Chloramine-T] | All purposes and products | 0.2 per cent | — | — |
| 6 | Chlorates of alkali metals | Toothpaste | 5 per cent | — | — |
| Other uses | 3 per cent | — | — | ||
| 7 | Dichloromethane | All purposes and products | 35 per cent (and when mixed with 1,1,1-trichloroethane, total concentration must not exceed 35 per cent) | Purity of the dichloromethane must be not less than 99.8 per cent | — |
| 8 | m- and p-Phenylenediamines, their N-substituted derivatives and their salts; N-substituted derivatives of o-phenylenediamines | Oxidizing colouring agents for hair-dyeing for general use | 6 per cent calculated as a free base, subject to the provision of “Combination Rule A” set out below | — | Contains phenylenediamines. Can cause an allergic reaction. Do not use to dye eyelashes or eyebrows |
| Oxidizing colouring agents for hair-dyeing for professional use | 6 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | — | Contains phenylenediamines. For professional use only. Can cause an allergic reaction. Wear suitable gloves | ||
| 9 | Methylphenylenediamines (other than 4-methyl-m-phenylenediamine and its salts), their N-substituted derivatives and their salts (Toluenediamines (other than toluene-1,3-diamine and its salts), their N-substituted derivatives and their salts) | Oxidizing colouring agents for hair-dyeing for general use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | — | Contains phenylenediamines. Can cause an allergic reaction. Do not use to dye eyelashes or eyebrows. |
| Oxidizing colouring agents for hair-dyeing for professional use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | — | Contains phenylenediamines. For professional use only. Can cause an allergic reaction. Wear suitable gloves | ||
| 10 | Diaminophenols | Oxidizing colouring agents for hair-dyeing for general use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | — | Contains diaminophenols. Can cause allergic reaction. Do not use to dye eyelashes or eyebrows |
| Oxidizing colouring agents for hair-dyeing for professional use | 10 per cent calculated as afree base, subject to the provisions of “Combination Rule A” set out below | — | Contains diaminophenols. For professional use only. Can cause allergic reaction. Wear suitable gloves | ||
| 11 | Dichlorophen (INN) [Dichlorophene] | All purposes and products | 0.5 per cent | — | Contains dichlorophen |
| 12 | Hydrogen peroxide and other compounds or mixtures that release hydrogen peroxide including hydrogen peroxide-urea (hydrogen peroxide-carbamide) and zinc peroxide | a Hair-care preparations b Skin-care preparations c Nail hardening preparations d Oral hygiene products | 12 per cent of H₂O₂ present or released 4 per cent of H₂O₂ present or released 2 per cent of H₂O₂ present or released 0.1 per cent of H₂O₂ present or released | — — — — | (a): Wear suitable gloves (a)(b)(c): Contains hydrogen peroxide. Avoid contact with eyes. Rinse eyes immediately if product comes into contact with them — |
| 13 | Formaldehyde (see also Part I of Schedule 4) | Nail hardeners | 5 per cent | — | Contains formaldehyde. Protect cuticles with grease or oil. (Not required when concentration is not more than 0.05 per cent) |
| 14 | Hydroquinone | Oxidizing colouring agent for hair dyeing for general use | 2 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains hydroquinone. Do not use to dye eyelashes or eyebrows. Rinse eyes immediately if product comes into contact with them |
| Oxidizing colouring agent for hair dyeing for professional use | 2 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains hydroquinone. For professional use only. Rinse eyes immediately if product comes into contact with them | ||
| Agents for localised skin lightener | 2 per cent | — | Contains hydroquinone. Avoid contact with eyes. Apply to small areas. If irritation develops discontinue use. Do not use on children under the age of 12 | ||
| 15a | Potassium hydroxide and sodium hydroxide (see Note 1) | Nail cuticle solvent | 5 per cent calculated as sodium hydroxide (see Note 2) | — | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children |
| Hair straightener for general use | 2 per cent calculated as sodium hydroxide (see Note 2) | — | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children | ||
| Hair straightener for professional use | 4.5 per cent calculated as sodium hydroxide (see Note 2) | — | For professional use only. Avoid contact with eyes. Can cause blindness | ||
| pH adjuster for depilatories | — | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with eyes | ||
| Other uses as pH adjuster | — | pH value not to exceed 11 | — | ||
| 15b | Lithium hydroxide | Hair straightener for general use | 2 per cent calculated as sodium hydroxide (see Note 2) | — | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children |
| Hair straightener for professional use | 4.5 per cent calculated as sodium hydroxide (see Note 2) | — | For professional use only. Avoid contact with eyes. Can cause blindness | ||
| Other uses | — | — | — | ||
| 15c | Calcium hydroxide | Hair straighteners containing two components: calcium hydroxide and guanidine salt | 7 per cent | — | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children |
| Other uses | — | — | — | ||
| 16 | α-Naphthol[1-Naphthol] | Colouring agent for hair dyeing | 0.5 per cent | — | Contains α-napthol |
| 17 | Sodium nitrite | Rust inhibitor | 0.2 per cent | Do not use with secondary and/or tertiary amines or other substances forming nitrosamines | — |
| 18 | Nitromethane | Rust inhibitor | 0.3 per cent | — | — |
| 19 | Phenol and its alkali salts | Soaps and shampoos | 1 per cent calculated as phenol | — | Contains phenol |
| 20 | ENTRY DELETED | ||||
| 21 | Quinine and its salts | Shampoos | 0.5 per cent calculated as quinine base | — | — |
| Hair lotions | 0.2 per cent calculated as quinine base | — | — | ||
| 22 | Resorcinol | Oxidizing colouring agent for hair dyeing for general use | 5 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains resorcinol. Rinse hair well after application. Do not use to dye eyelashes or eyebrows. Rinse eyes immediately if product comes into contact with them |
| Oxidizing colouring agent for hair dyeing for professional use | 5 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains resorcinol. For professional use only. Rinse eyes immediately if product comes into contact with them | ||
| Hair lotions and shampoos | 0.5 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains resorcinol | ||
| 23a | Alkali sulphides | Depilatories | 2 per cent calculated as sulphur | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with eyes |
| 23b | Alkaline earth sulphides | Depilatories | 6 per cent calculated as sulphur | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with eyes |
| 24 | Water-soluble zinc salts with the exception of zinc 4-hydroxybenzenesulphonate | All purposes and products | 1 per cent calculated as zinc | — | — |
| 25 | Zinc 4-hydroxybenzene-sulphonate [Zinc phenolsulfonate] | Deodorants, antiperspirants and astringent lotions | 6 per cent calculated as percentage of anhydrous substance | — | Avoid contact with eyes |
| 26 | Ammonium monofluorophosphate | Oral hygiene products | 0.15 per cent calculated as fluorine. When mixed with other fluorine compounds the total fluorine concentration must not exceed 0.15 per cent | — | Contains ammonium monofluorophosphate |
| 27 | Sodium monofluorophosphate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains sodium monofluorophosphate |
| 28 | Potassium monofluorophosphate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains potassium monofluorophosphate |
| 29 | Calcium monofluorophosphate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains calcium monofluorophosphate |
| 30 | Calcium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains calcium fluoride |
| 31 | Sodium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains sodium fluoride |
| 32 | Potassium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains potassium fluoride |
| 33 | Ammonium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains ammonium fluoride |
| 34 | Aluminium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains aluminium fluoride |
| 35 | Stannous fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains stannous fluoride |
| 36 | Hexadecylammonium fluoride [Cetylamine hydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains hexadecylammonium fluoride |
| 37 | 3-(n-Hexadecyl-N-2-hydroxyethylammonio)-propylbis(2-hydroxyethyl)-ammonium difluoride [Stearyl trihydroxyethyl propylenediamine dihydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains 3-(n-hexadecyl-N-2-hydroxyethylammonio)propylbis(2-hydroxyethyl)ammonium difluoride |
| 38 | N,N',N'-Tris(polyoxyethylene)-N-hexadecylpropylenediamine dihydrofluoride [Palmityl trihydroxyethyl propylenediamine dihydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains N,N',N'-tris(polyoxyethylene)-N-hexadecylpropylenediamine dihydrofluoride |
| 39 | Octadecenylammonium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains octadecenylammonium fluoride |
| 40 | Sodium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains sodium fluorosilicate |
| 41 | Potassium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains potassium fluorosilicate |
| 42 | Ammonium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains ammonium fluorosilicate |
| 43 | Magnesium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains magnesium fluorosilicate |
| 44 | 1,3-Bis(hydroxymethyl)-imidazolidene-2-thione [Dimethylol ethylene thiourea] | Hair care preparations | 2 per cent | Not to be used in aerosol dispensers | Contains 1,3-bis(hydroxymethyl)imidazolidene-2-thione |
| Nail care preparations | 2 per cent | pH value as applied must be less than 4 | Contains 1,3-bis(hydroxymethyl)imidazolidene-2-thione | ||
| 45 | Benzyl alcohol (See also Part I of Schedule 4) | Solvent, perfumes and flavourings | — | — | — |
| 46 | 6-Methylcoumarin | Oral hygiene products | 0.003 per cent | — | — |
| 47 | Nicomethanol hydrofluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains nicomethanol hydrofluoride |
| 48 | Silver nitrate | Products to dye eyelashes or eyebrows | 4 per cent | — | Contains silver nitrate. Rinse eyes immediately if product comes into contact with them |
| 49 | Selenium disulphide [Selenium sulfide] | Anti-dandruff shampoos | 1 per cent | — | Contains selenium disulphide. Avoid contact with eyes or damaged skin |
| 50 | Aluminium zirconium chloride hydroxide complexes AlxZr(OH)yClz and aluminium zirconium chloride hydroxide glycine complexes | Anti-perspirants | 20 per cent as anhydrous aluminium zirconium chloride hydroxide, 5.4 per cent as zirconium | The ratio of the number of aluminium atoms to that of zirconium atoms must be between 2 and 10 The ratio of the number of (Al+Zr) atoms to chlorine atoms must be between 0.9 and 2.1 Not to be used in aerosol dispensers (sprays) | Do not apply to irritated or damaged skin |
| 51 | Quinolin-8-ol and bis(8-hydroxyquinolinium sulphate) (See also Part II of this Schedule) [Oxyquinoline and Oxyquinoline sulfate] | Stabilizer for hydrogen peroxide in rinse-off hair care preparations | 0.3 per cent calculated as base | — | — |
| Stabilizer for hydrogen peroxide in non rinse-off hair care preparations | 0.03 per cent calculated as base | — | — | ||
| 52 | Methanol | Denaturant for ethanol and isopropyl alcohol | 5 per cent calculated as a percentage of ethanol and isopropyl alcohol | — | — |
| 53 | Etidronic acid and its salts (1-hydroxyethylidene-diphosphonic acid and its salts) | Hair care Soap | 1.5 per cent expressed as etidronic acid 0.2 per cent expressed as etidronic acid | — — | — — |
| 54 | 1-Phenoxypropan-2-ol (See also Part I of Schedule 4) [Phenoxyisopropanol] | Products rinsed off after use. Prohibited in oral hygiene products | 2 per cent | — | — |
| 55 | Lead acetate | Only for hair dyeing | 0.6 per cent calculated as lead | — | Contains lead acetate. Keep away from children. Avoid all contact with the eyes. Wash hands after use. Do not use to dye eyelashes, eyebrows or moustaches. If irritation develops discontinue use |
| 56 | Magnesium fluoride | Dental hygiene products | 0.15 per cent calculated as fluorine. When mixed with other fluorine compounds the total fluorine concentration must not exceed 0.15 per cent | — | Contains magnesium fluoride |
| 57 | Strontium chloride hexahydrate | Toothpaste | 3.5 per cent calculated as strontium. When mixed with other permitted strontium compounds the total strontium content must not exceed 3.5 per cent | — | Contains strontium chloride. Use by children is not advisable |
| 58 | Strontium acetate hemihydrate | Toothpaste | 3.5 per cent calculated as strontium. When mixed with other permitted strontium products the total strontium content must not exceed 3.5 per cent | — | Contains strontium acetate. Use by children is not advisable |
| 59 | Talc: hydrated magnesium silicate | (a) Powdery products intended to be used for children under three years of age | — | — | (a): Keep powder away from children’s nose and mouth |
| (b) other products | — | — | |||
| 60 | Fatty acid dialkanolamides | All purposes and products | Maximum dialkanolamine content: 0.5 per cent | Do not use with nitrosating systems. Maximum dialkanolamine content: 5 per cent (applies to raw materials). Maximum N-nitrosodialkanolamine content: 50 μ g/kg (applies to raw materials). Keep in nitrite-free containers | — |
| 61 | Monoalkanolamines | All purposes and products | Maximum dialkanolamine content: 0.5 per cent | Do not use with nitrosating systems. Minimum purity: 99 per cent. Maximum dialkanolamine content: 0.5 per cent (applies to raw materials). Maximum N-nitrosodialkanolamine content: 50 μ g/kg (applies to raw materials). Keep in nitrite-free containers | — |
| 62 | Trialkanolamines | a non-rinse-off b other products | a 2.5 per cent | (a) (b): Do not use with nitrosating systems. Minimum purity: 99 per cent. Maximum dialkanolamine content: 0.5 per cent (applies to raw materials). Maximum N-nitrosodialkanolamine content: 50 μ g/kg (applies to raw materials). Keep in nitrite-free containers | — |
| 63 | Strontium hydroxide | pH-regulator in depilatory products | 3.5 per cent calculated as strontium | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with the eyes |
| 64 | Strontium peroxide | Rinse-off hair care preparations for professional use | 4.5 per cent calculated as strontium in the ready-for-use preparation | All products must meet the hydrogen peroxide release requirements | Avoid contact with eyes. Rinse eyes immediately if product comes into contact with them. For professional use only. Wear suitable gloves |
PART II — SUBSTANCES LISTED IN ANNEX III, PART 2 (FORMERLY ANNEX IV, PART 1) OF THE DIRECTIVE AS SUBSTANCES PROVISIONALLY ALLOWED
Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.
This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence.
legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.